Antivirals Global Market Sees Growth Rate Of 13% Through 2022

The global antivirals market size is expected to grow from $85.08 billion in 2021 to $96.46 billion in 2022 at a compound annual growth rate (CAGR) of 13.4%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global anti-viral drug therapy market size is expected to reach $149.21 billion in 2026 at a CAGR of 11.5%.

What is the Global Antivirals Market?

The anti-viral drug therapy market consists of sales of anti-viral drugs used for the treatment of viral infections, such as human immunodeficiency virus (HIV), hepatitis, influenza and novel coronavirus. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The anti-viral drugs establishments are primarily engaged in the manufacturing of DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, neuraminidase inhibitors, and others.

Get a Sample of the global antivirals market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2437&type=smp

What drives the Global Antivirals Market?

The demand for anti-viral drugs is anticipated to grow at a rapid pace due to the novel coronavirus outbreak. As there are no vaccines and potential treatments for COVID-19, companies are trying to repurpose existing drugs in the fight against the novel coronavirus. The use of certain existing anti-viral drugs for the COVID-19 treatment is contributing to the growth of anti-viral drugs market. However, if any of these drugs under trails show further promising results in treating the coronavirus infection, the anti-viral market will see further growth.

Get the full global antivirals industry report here

Global Antivirals Market Segments
The global antivirals market is segmented:
By Drug Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others
By Application: HIV, Hepatitis, Herpes, Influenza, Others
By Type: Branded, Generic
By Geography: The regions covered in the antivirals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Antivirals Global Market Report 2022 provides market size and growth forecasts for the global antivirals market, global antivirals market share, antivirals market segments and geographies, antivirals market competitive landscape including leading competitors’ revenues, profiles and market shares. The antivirals market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Antivirals Industry Playersinclude AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd, AstraZeneca plc., Aurobindo Pharma, Abbott Laboratories, Schering-Plough Corporation, Pfizer Inc., Sanofi, Regeneron Pharmaceuticals, Inc., Inovio Pharmaceuticals, Inc., Novavax, Inc., and BioCryst Pharmaceuticals, Inc. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.